Renin-Angiotensin System Inhibitors vs. Other Antihypertensive Drug Classes for ...
Nov 1, 2019 - RAS inhibitors, which include angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, and renin inhibitors, should not be used as first-line agents.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/1101/p540.html
Blood Pressure Targets for Patients with Hypertension and Cardiovascular Disease - ...
Sep 1, 2018 - Achieving a target BP of 135/85 mm Hg or less does not decrease the risk of total cardiovascular events vs. treating to a target of 140 to 160/90 to 100 mm Hg. Further, treating to the lower BP target does not improve total mortality, cardiovascular mortality, or serious adverse effects.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2018/0901/p276.html
ACE Inhibitors vs. ARBs for Primary Hypertension - Cochrane for Clinicians - American ...
Apr 15, 2015 - ACE inhibitors and ARBs have similar effects on cardiovascular outcomes and total mortality in head-to-head trials. However, slightly more adverse effects were noted in patients assigned to ACE inhibitor therapy.
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2015/0415/p522.html
Effectiveness and Safety of Factor Xa Inhibitors in Patients with Atrial Fibrillation -...
Oct 1, 2019 - Treatment of AFib with a factor Xa inhibitor results in a decrease in the combined end point of stroke and embolic events (odds ratio [OR] = 0.89; 95% CI, 0.82 to 0.97), as well as a decrease in intracranial hemorrhage (OR = 0.50; 95% CI, 0.42 to 0.59) and all-cause mortality (OR = ...
American Family Physician : Cochrane for Clinicians
https://www.aafp.org/afp/2019/1001/p405.html
navigate_before 1 navigate_next